T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2018-08-25
DOI
10.1080/2162402x.2018.1494112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics
- (2017) Meghan J Mooradian et al. Future Oncology
- Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas
- (2017) Kate Poropatich et al. JOURNAL OF PATHOLOGY
- Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma
- (2017) Lijun Shi et al. Oncotarget
- Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study
- (2017) Atsutoshi Tomino et al. PLoS One
- CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer
- (2016) Raghvendra M. Srivastava et al. CLINICAL CANCER RESEARCH
- Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- T-cell receptor profiling in cancer
- (2015) Ilan Kirsch et al. Molecular Oncology
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy
- (2015) T. Ochi et al. Cancer Immunology Research
- Immune monitoring technology primer: immunosequencing
- (2015) Ilan Kirsch Journal for ImmunoTherapy of Cancer
- PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment
- (2014) J. Li et al. CANCER RESEARCH
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- (2014) L. Robert et al. CLINICAL CANCER RESEARCH
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
- (2014) E. Cha et al. Science Translational Medicine
- Characterizing immune repertoires by high throughput sequencing: strategies and applications
- (2014) Jorg J.A. Calis et al. TRENDS IN IMMUNOLOGY
- Functional TCR Retrieval from Single Antigen-Specific Human T Cells Reveals Multiple Novel Epitopes
- (2014) P. Simon et al. Cancer Immunology Research
- Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
- (2013) P Balermpas et al. BRITISH JOURNAL OF CANCER
- TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
- (2013) Ryan M. Stephenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
- (2013) S. Munir et al. CANCER RESEARCH
- Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen-Specific T-cell Immunity in Head and Neck Cancer Patients
- (2013) R. M. Srivastava et al. CLINICAL CANCER RESEARCH
- TCR repertoires of intratumoral T-cell subsets
- (2013) Carsten Linnemann et al. IMMUNOLOGICAL REVIEWS
- High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer
- (2013) Ryan O Emerson et al. JOURNAL OF PATHOLOGY
- Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation
- (2013) Jeroen W J van Heijst et al. NATURE MEDICINE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+head and neck cancer cells
- (2013) Chwee Ming Lim et al. OncoImmunology
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
- (2011) Steve C. Lee et al. IMMUNOLOGIC RESEARCH
- Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro
- (2011) P. Correale et al. INTERNATIONAL JOURNAL OF CANCER
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Antigen-Driven Patterns of TCR Bias Are Shared across Diverse Outcomes of Human Hepatitis C Virus Infection
- (2010) J. J. Miles et al. JOURNAL OF IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search